Related Experiment Video
Updated: Feb 16, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Association of ANRIL Expression with Coronary Artery Disease in Type 2 Diabetic Patients
Esmaeil Rahimi1, Amirhossein Ahmadi1, Mohammad Ali Boroumand2
1Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
Objectives:
ANRIL is an important antisense noncoding RNA gene in the INK4 locus (9p21.3), a hot spot region associated with multiple disorders including coronary artery disease (CAD), type 2 diabetes mellitus (T2DM) and many different types of cancer. It has been shown that its expression is dysregulated in a variety of immune-mediated diseases. CAD is a major problem in T2DM patients and the cause of almost 60% of deaths in these patients worldwide. The aim of the present study was to compare the expression level of ANRIL between T2DM patients with and without CAD.
Materials And Methods:
In this case-control study, we examined ANRIL expression in peripheral blood mononuclear cell samples by quantitative reverse transcription- polymerase chain reaction (RT-qPCR) in 64 T2DM patients with and without CAD (33 CAD+ and 31 CAD- patients respectively, established by coronary angiography).
Results:
Expression analysis revealed that ANRIL was up regulated (2.34-Fold, P=0.012) in CAD+ versus CADdiabetic patients. Data from receiver operating characteristic (ROC) curve analysis has shown that ANRIL could act as a potential biomarker for detecting CAD in diabetic patients.
Conclusions:
The expression level of ANRIL is associated with presence of CAD in diabetic patients and could be considered as a potential peripheral biomarker.
Insights
Antisense noncoding RNA in INK4 locus (ANRIL) expression is elevated in type 2 diabetes mellitus (T2DM) patients with coronary artery disease (CAD). ANRIL may serve as a biomarker for detecting CAD in diabetic individuals.
Area of Science:
- Genetics and Molecular Biology
- Cardiovascular Disease Research
- Endocrinology and Metabolism
Background:
- The INK4 locus harbors the ANRIL gene, a key player in various diseases including coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM).
- ANRIL expression is frequently altered in immune-mediated conditions, and CAD significantly impacts T2DM patient mortality.
- Understanding ANRIL's role in T2DM patients with CAD is crucial for identifying potential diagnostic markers.
Purpose of the Study:
- To investigate and compare ANRIL gene expression levels in T2DM patients, differentiating between those with and without CAD.
- To evaluate ANRIL as a potential biomarker for CAD in the context of type 2 diabetes.
Main Methods:
- A case-control study design was employed.
- ANRIL expression was quantified using quantitative reverse transcription-polymerase chain reaction (RT-qPCR) in peripheral blood mononuclear cells.
- The study included 64 T2DM patients, categorized into CAD-positive (n=33) and CAD-negative (n=31) groups based on coronary angiography.
Main Results:
- ANRIL expression was significantly upregulated (2.34-fold, P=0.012) in T2DM patients with CAD compared to those without CAD.
- Receiver operating characteristic (ROC) curve analysis indicated that ANRIL has potential as a biomarker for CAD detection in diabetic patients.
Conclusions:
- Elevated ANRIL expression levels are associated with the presence of CAD in patients with type 2 diabetes mellitus.
- ANRIL demonstrates potential as a peripheral biomarker for identifying coronary artery disease in diabetic individuals.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures

